IPM has created what it has described as a $100 million venture capital fund that will provide backing to both private drug developers and nonprofits to invest in product development relating to the development of microbicides.
IPM Headquarter Location
1010 Wayne Avenue Suite 1450
Silver Spring, Maryland, 20910,
1 Team Member
IPM has 1 team member, including current Chief Executive Officer, Zeda Rosenberg.